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bChief, Division of Pediatric Cardiac Surgery, Children’s Heart Center, Kokilaben Dhirubhai Ambani Hospital, Mumbai, IndiaWhen most of the centers in India do not entertain the
patients with hypoplastic left heart syndrome, the original
authors of the article in the present issue should be congrat-
ulated for the attempt of treating this patient with hybrid
procedure. It’s a spectacular beginning.
The development of staged reconstructive surgery for
hypoplastic left heart syndrome (HLHS) by Norwood and
colleagues in early 1980 has radically altered the prognosis of
this most complex heart problem.1 The important anatomical
features of HLHS are severe aortic andmitral valve hypoplasia
or atresia with underdevelopment of left ventricle and varying
degrees of hypoplasia of aortic arch. Reconstructive surgery
for this condition, which is essentially a long-term
palliation, is traditionally performed in three stages. The
first stage is performed within the first few days of life
which consists of reconstruction of ascending hypoplastic
aorta using proximal main pulmonary artery, removal of
interatrial septum and insertion of systemic to pulmonary
artery shunt or a right ventricle to pulmonary artery shunt
(Sano shunt) to maintain pulmonary blood flow. The second
stage is bidirectional Glenn shunt which is carried out
between 4e12 months and the third stage is completion
Fontan which is performed by 2e6 years of age.
Recently an innovative technique has been described in
which stenting of ductus arteriosus is performed in the
cardiac catheterization laboratory and bilateral pulmonary
arterial banding is done by the surgeons.2 This technique is
labeled as “Hybrid Procedure”. In this issue of Indian Heart
Journal Anuradha et al from Frontier Lifeline Hospital,
Chennai have described a case in which they performed
Hybrid Stage 1 palliation for hypoplastic left heart syndrome
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a stent in the duct and pulmonary artery banding, the
authors have placed a stent in the ascending aorta because
of extensive arch hypoplasia. Potential advantage of the
hybrid technique is avoidance of circulatory arrest in the
early neonatal period and shifting the major surgical stage
to later period until the brain is more developed. The
primary goal of the procedure is to create a stable and
balanced circulation without the use of open-heart surgery
with its associated risk in a neonate. By shifting the age of
bypass, there may be a dramatic impact to the patients
neurologic development. Both these strategies have
a common goal. They provide unobstructed systemic cardiac
output, controlled source of pulmonary blood flow, reliable
source of coronary blood flow and unobstructed egress of
pulmonary venous drainage. The initial experience of hybrid
technique is still developing and will have to demonstrate
superior outcomes to the more traditional strategy. We have
to study the hemodynamics of this child after 3 months as it
is sometimes very difficult to control the pulmonary blood
flow with this technique. In addition, extensive arch repair
is a major advantage by surgery which determines the long-
term outcomes of the Fontan procedure.
The procedure described in this issue was performed in
the conventional cardiac catheterization laboratory. Ideally
these procedures are performed in “Hybrid Suites”. These
suites are designed around the cardiac surgeons and cardiac
surgical patients offering advanced access and imaging in the
operating room. There is no need to shift these critically ill
patients from catheterization laboratory to surgical theaters.
The suites accommodate collective catheterization and
surgical team and facilitate rapid information sharing. Theseai Ambani Hospital, Four Bungalows, Andheri (west), Mumbai
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with the present numbers of patients who may need this
facility.
Diagnosis of HLHS can be made easily in fetal life. It is
a silent disease in utero and most of these fetuses complete
the gestational term. Inherent tricuspid regurgitation may
exist and might progress with gestation and is an important
risk factor for poor post-surgical outcome. Size of the intera-
trial septal defect has a bearing in the development of the
pulmonary vasculature and ultimate outcome. The ability to
diagnose the lesion with certainty in fetal life and the
extremely poor outcome in HLHS with intact or restrictive
interatrial septum becomes a potential prenatal intervention
for these babies in the form of balloon atrial septostomy.
Babies born with HLHS need stabilization with PGE1 infusion
immediately after birth to keep the ductal patency and
maintain the perfusion of lower body and retrograde perfu-
sion of cerebral and coronary circulation.
As corrective surgery for many biventricular heart lesions
has become a real possibility, more and more neonates with
biventricular hearts are undergoing the required procedure
early in life with excellent long-term outcomes. There has
been steady improvement in terms of miniature hardware,
micro instrumentation, advanced miniature cardio pulmo-
nary bypass circuits with oxygenators along with improve-
ment in care of these newborns in the postoperative phase.
Today there is a pattern of predictability even in preterm and
low birth weight babies with congenital heart defects with
good chances of survival after corrective surgery.
However the story with HLHS is more complicated as there
is a great variability in the anatomic substrate. The anatomy
varies from severe hypoplasia of mitral, aortic valves, aortic
atresia with hypoplastic aorta to reasonable sized left
ventricle with severe left ventricular outflow obstruction
where surgical options can be quite different. Mortality figures
for stage I Norwood is center specific withmortality rates vary
from 5e10% in experienced hands to in excess of 20% in
developing countries. The improved survival after stage 1
Norwood has resulted in acknowledging the existence of
interstage mortality upto 10%. We need to see whether the
hybrid procedure addresses these issues on long-term follow-
up. There has been a tilt toward early second stage in the form
of a bidirectional Glenn or a hemifontan operation around 5e6
months of age. Morbidities such as exercise intolerance,
arrhythmias, thromboembolic diseases, protein loosing
enteropathy and neurocognitive disorders have come to light
in some of these children reaching teenage like other Fontan
procedures. The eventual long-term survival after 3 stage
reconstructive procedure for HLHS depends upon the right
(neo-systemic) ventricular function and the degree of
tricuspid regurgitation. Some of these survivors will need
heart transplant owing to a failing Fontan in the years to
come. In the long term there is uncertainty with the patients
with HLHS with Fontan circulation as the right ventricle
remains as systemic pump. Continuing improvements in
surgical techniques may not only minimize peri and post-
operative mortality but also reduce the risk of complications
in the medium and long term. Otherwise heart trans-
plantation remains the only option for these failing Fontan
circulation.Antenatal diagnosis has a major important role which
allows the parents to consider treatment options and to
arrange for a elective delivery in a specialized center. It can
define the unfavorable intracardiac anatomy and presence of
extracardiac defects which help parents to take decision. It
also allows for a coordinated services to be provided between
fetal cardiology, neonataology, pediatric cardiology and
cardiac surgery. In order to counsel the parents antenatally, it
is essential to understand the natural history of this condi-
tion.3,4 Confirmed or suspected genetic syndromes are
frequent in patients with HLHS. Because early surgical palli-
ation is necessary, identifying risk factors for worsened neu-
rodevelopmental outcomes can be difficult. After the surgery,
about 8e10% patients need ECMO support. There is a need to
see long-term neurodevelopmental outcomes of these
patients. Larger series have shown significant neuro-
developmental disabilities in upto 65% of patients.5 The
hybrid procedures may prove superior to avoid these
complications.
As far as the Indian scenario is concerned, with the inci-
dence of HLHS about 0.1e0.25/1000 live births, we should
expect about 2000 babies with HLHS born every year. In reality
the total number of babies with HLHS seen inmajor centers in
India will not be more than 100 children/year. Most of the
fetuses with diagnosis of HLHS get terminated by parents
options and counseling offered to them by perinatologists.
The termination rates are quite high with additional extrac-
ardiac abnormalities with abnormal karyotyping. As these
neonates are very sick after birth, unless a correct diagnosis is
made and appropriate treatment is started for stabilization,
there is a very high chance of early neonatal loss. As a result,
very few neonates reach the tertiary care centers for evalua-
tion and further management options. In the absence of
prenatal diagnosis, most of these newborns present in a very
sick and metabolically compromised state where the success
rates of 1st stage Norwood repair are very low.
There are certain ethical, social and financial issues to be
considered with us in India. Only a fraction of population has
insurance cover. The young parents have to fund these oper-
ations from their meager savings and whether they will be
able to fund all the three stages of operations is a big question
mark. After counseling and knowing the need for multistaged
repair, most of the parents opt for compassionate care and
will not like do activemanagement. They instead look forward
to have a normal child in future. Very few parents want to go
ahead with the complex management options in a precious
child especially if the baby is born with assisted reproductive
techniques. Unfortunately we have not been able to develop
enough expertise to treat this condition as each center deals
with a small number of babies. We need a team approach to
take care of these complex anomalies which include expertise
in pediatric cardiology, cardiac surgery, anesthesia, intensive
care and perfusion. It’s an expensive affair.
Few centers in India have performed classical Norwood
procedures. Our center has performed total six classical Nor-
wood procedures till date. The surgeons performed extensive
arch repair with Damus Kaye Stansel procedure and modified
BlalockeTaussig shunt. Four patients had classical anatomy
of HLHS i.e. mitral atresia with aortic atresia and hypoplastic
aortic arch. Two had univentricular hearts with severe
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the first stage. Out of the three patients who did not survive
the first stage, one baby was in severe low cardiac output with
metabolic acidosis on presentation and the other two had
severe tricuspid regurgitation. Retrospectively we thought
that they were not the ideal candidates in the beginning of the
program. Two patients underwent the second stage of Nor-
wood repair i.e. bidirectional Glenn shunt and the third is
awaiting.
The western world has already completed three decades of
taking care of this complex defects and their earlier operated
patients have already reached in twenties. They have over-
come the initial hitches. What strategy should we follow? All
the centers may not be able to offer the same survival
statistics based on their own experiences. This raises the
question of regionalization of care and referral to centers of
excellence specifically identified as able to treat this
anomaly.6,7 A regional referral center which has a track record
of handling neonates successfully should gradually develop
the needed expertise. Survival rates can improve when the
procedure and postoperative care is taken care of by experi-
enced hands.r e f e r e n c e s
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